EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitVergleichsstudieOpen Access · CC BY 4.0

Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective

Zelong Zheng, Ami Kobayashi iD, Yosuke Kitagawa iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27104495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Zelong Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Central Nervous System Neoplasms, Fluorescent Dyes, Glioblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Shinnihon Foundation, Chugai Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraoperative fluorescence-guided surgery is an important adjunct to brain tumor resection. However, fluorescent probe performance varies across molecularly and histopathologically distinct entities, including IDH-wildtype glioblastoma, metastatic brain tumors (MBTs), and primary central nervous system lymphoma (PCNSL), and the mechanisms underlying this variability remain poorly understood. We propose a mechanistic framework integrating biomechanical constraints, molecular barrier heterogeneity, and probe-specific pharmacokinetics to explain cross-tumor differences in fluorescence signal. Probe performance is conceptualized through three sequential bottlenecks: extravasation (blood–brain barrier/blood–tumor barrier permeability and transcytosis), interstitial penetration (extracellular matrix density and hydraulic resistance), and retention/clearance (efflux transporters and metabolic processing). An overlying optical layer, including tissue absorption, scattering, and autofluorescence, further modulates the detected signal. Tumor-specific molecular heterogeneity critically shapes these processes. In IDH-wildtype glioblastoma and legacy high-grade glioma cohorts, heterogeneous expression of ATP-binding cassette transporters has been associated with reduced intracellular accumulation of protoporphyrin IX after 5-aminolevulinic acid administration and may contribute to false-negative fluorescence in selected tumor regions. In MBTs, stage-dependent blood–tumor barrier integrity and vascular programs influence probe delivery, whereas in PCNSL, corticosteroid-sensitive restoration of endothelial barrier function may compromise the performance of leakage-dependent tracers. Together, this framework highlights how tumor biology, barrier function, and probe pharmacology jointly shape fluorescence contrast. Rational probe selection informed by tumor-specific transport and barrier constraints may improve intraoperative visualization of brain tumors and optimize surgical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCentral Nervous System NeoplasmsFluorescent DyesGlioblastomaIsocitrate DehydrogenaseLymphomaHumansBlood-Brain Barrier

Stichwörter der Autor:innen

IDH-wildtype glioblastomafluorescent probesmetastatic brain tumorsprimary central nervous system lymphomaresection

Substanzen

Fluorescent DyesIsocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Department of Neurosurgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
  • Department of Medical Sciences and Innovation, Institute of Medical Research, Tohoku University, Sendai 980-8574, Japan.
  • Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan.

ORCID-Profile: Ami Kobayashi, Yosuke Kitagawa

Förderung

  • The Shinnihon Foundation
  • Chugai Foundation
  • Japan Society for the Promotion of Science
  • The Japanese Congress of Neurological Surgeons

Zitieren

APA

Zheng, Z., Kobayashi, A., & Kitagawa, Y. (2026). Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104495

Vancouver

Zheng Z, Kobayashi A, Kitagawa Y. Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104495

BibTeX
@article{Zheng2026,
  author = {Zheng, Zelong and Kobayashi, Ami and Kitagawa, Yosuke},
  title = {Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27104495}
}
Kostenlos starten →